thiotepa has been researched along with Carcinoma, Basal Cell, Pigmented in 2 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vollebergh, MA | 1 |
Lips, EH | 1 |
Nederlof, PM | 1 |
Wessels, LFA | 1 |
Schmidt, MK | 1 |
van Beers, EH | 1 |
Cornelissen, S | 1 |
Holtkamp, M | 1 |
Froklage, FE | 1 |
de Vries, EGE | 1 |
Schrama, JG | 1 |
Wesseling, J | 1 |
van de Vijver, MJ | 1 |
van Tinteren, H | 1 |
de Bruin, M | 1 |
Hauptmann, M | 1 |
Rodenhuis, S | 1 |
Linn, SC | 1 |
Moskalik, KG | 1 |
Kozlov, AP | 1 |
Akimov, AA | 1 |
1 review available for thiotepa and Carcinoma, Basal Cell, Pigmented
Article | Year |
---|---|
[Use of optical quantum generators (lasers) in oncology].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bronchial Neoplasms; Carcinoma, Basal Cell; Carcinom | 1972 |
1 trial available for thiotepa and Carcinoma, Basal Cell, Pigmented
Article | Year |
---|---|
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; Breast Neoplasms; Carboplatin; | 2011 |